Background: Recent evidence that programmed intermittent epidural bolus (PIEB) improves maternal outcomes encouraged us to change our labour epidural analgesia protocols and investigate if we could achieve similar results in a clinical setting. Methods: We conducted a prospective, controlled, before-and-after cohort study. Outcomes after labour analgesia delivered by continuous epidural infusion (CEI) with ropivacaine 0.2% and fentanyl 2mg ml À1 were compared with PIEB
In New South Wales, Australia, 35% of women in public hospitals and 53% in private hospitals elect to have an epidural for labour pain. 1 Until recently, the standard analgesic regimen was a local anaesthetic combined with an opioid delivered by a continuous epidural infusion (CEI) 1, 2 or CEI combined with patient controlled epidural analgesia (PCEA). 3 Intermittent boluses of solution at regular intervals can spread more extensively in the epidural space compared with a continuous infusion, 4 possibly enabling greater therapeutic efficacy. Evidence from randomised controlled trials (RCTs) shows that that programmed intermittent epidural bolus (PIEB) can achieve lower rates of motor block and shortened second stage of labour with similar or better patient satisfaction outcomes using a lower total dose of local anaesthetic. 2 We conducted a prospective, controlled, before-and-after cohort study to evaluate the change from CEI to PIEBþPCEA for providing epidural analgesia during labour in a metropolitan tertiary referral hospital located in Sydney, New South Wales, Australia. Our aims were to translate the best available evidence for a promising intervention into clinical practice, to evaluate its effectiveness based on patient-centred labour outcomes, and to externally validate the evidence from small RCTs in a larger population in the complexities of the 'real world'.
Methods
This article was prepared in accordance with guidelines for Strengthening the Reporting of OBservational studies in Epidemiology (STROBE). 5 
Study design
This is a prospective, controlled, before-and-after cohort study designed to evaluate the effectiveness of PIEBþPCEA vs CEI for labour analgesia. This study was approved by the Western Sydney Local Health District Human Research Ethics Committee [HREC2014/11/5.2(4138)]. Written informed consent was not required by the ethics committee as the study related to an evidence-based institutional change of practice.
Setting and participants
Blacktown Hospital is a tertiary referral hospital located in Sydney, New South Wales, Australia. The obstetric unit handles about 3000 deliveries per year with a lower segment Caesarean section (LSCS) rate of 28% and epidural rate of 21%. All women who received epidural analgesia for planned normal vaginal delivery were eligible for inclusion in the study. Exclusion applied to women who received less than 10 ml of the epidural solution.
The study took place between December 2014 and September 2015, allowing a comparison period of 5 months before and after the change in the standard epidural infusion protocol. Before May 2015, our standard epidural infusion protocol for labour analgesia consisted of a continuous infusion of ropivacaine 0.2% with fentanyl 2mg ml À1 (5e15 ml h À1 ) (CEI group). From May 2015, we changed the protocol to ropivacaine 0.1% with fentanyl 2 mg ml À1 with an hourly programmed intermittent bolus of 5 ml plus a PCEA programme of 5 ml bolus with a 10 min lockout period (PIEBþPCEA group). The PIEB bolus volume could be increased up to 10 ml if required. In all cases, the epidural catheter was inserted according to standard protocols by trained anaesthetic staff, and an initial loading dose of bupivacaine 0.125%, 15e20 ml with fentanyl 5 mg ml À1 was given. The loading dose was not included in the total dose analysis as it was part of standard protocol for both groups. An epidural infusion was commenced 30e60 min after insertion of the epidural. CEI was turned down to 2 ml h À1 when the midwife assessed the woman was ready to start the second stage of labour, while PIEBþPCEA was continued until delivery.
The follow-up and data collection was performed by the acute pain clinical nurse consultant or an anaesthetic registrar.
Data collection
Patient characteristic data collected about the study participants included maternal age, parity, and gestational age.
The primary outcome was the prevalence of lower limb motor block defined as any weakness in the lower limbs according to the Bromage scale (grade IIeIV) and was assessed every two hours from the time of insertion by the midwife during labour.
The secondary outcomes were total local anaesthetic dose, total fentanyl dose, duration of the second stage of labour, mode of delivery, hypotension requiring resuscitation, and maternal satisfaction during the first and second stages of labour. Maternal satisfaction was elicited at the epidural review on the day after delivery using a 10-point verbal numeric rating scale.
The epidural solution was administered by a CADD 
Statistical analysis
Statistical analysis was performed using SAS ® software (version 9.3, SAS Institute Inc., Cary, NC, USA).
Editor's key points
Reduced motor block and labour duration may result from optimising epidural analgesia. This evaluation of changing labour analgesia protocols assessed different dosing schedules and modes. Intermittent epidural bolusing plus patient controlled epidural analgesia reduced motor block compared with continuous infusion. Second stage of labour duration was reduced, but there was no difference in overall satisfaction. This service evaluation reflects differences between randomised controlled trial evidence and clinical practice.
Continuous variables were reported as mean [standard deviation (SD)], and compared using the t-test. Categorical variables were reported as frequency (percentage) and compared using the c 2 test or Fisher's exact test. Subgroup analyses were performed in primiparous and multiparous women.
Significant differences between the two study groups found on univariate testing were further evaluated by multiple regression analysis to adjust for any potential confounding effects of baseline characteristics. Regression and normality assumptions, collinearity, interaction effects, and goodness of fit were examined and confirmed to be satisfactory. Regression coefficients were reported for linear regression models and odds ratios (OR) for logistic regression models, with 95% confidence intervals (CI). A conservative significance level of a¼0.01 was applied to all statistical tests to adjust for multiple comparisons.
Sample size
A minimum sample size of 149 per group was required for a two-sample test of proportions with power 1Àb¼0.90 and significance level a¼0.01 based on the estimated prevalence of motor block of 16% in the CEI group and 3% in the PIEB group. 2 We estimated that a recruitment period of 3e4 months per group would be required based on delivery rates and epidural rates at our institution. We conducted the comparison over a period of 5 months before and after the change in the standard epidural infusion protocol to allow a margin for potential deviation from projected recruitment rates and drop-outs.
Results
A total of 397 women completed the study: 188 women received CEI and 209 women received PIEBþPCEA (Fig. 1) . Of the 233 women initially enrolled into the CEI group, 41 received less than 10 ml of the epidural solution and four had incomplete data. Of the 236 women initially enrolled into the PIEBþPCEA group, 27 received less than 10 ml of the epidural solution. There were no significant baseline patient characteristic differences between the two groups (Table 1) .
There was no significant difference in the total epidural infusion volume received, or total fentanyl dose received. The total dose of ropivacaine received by women in the CEI group was nearly double that in the PIEBþPCEA group [CEI 72. 5 Table 2 ).
The prevalence of motor block in the PIEBþPCEA group was 1.0%, which was significantly lower compared with 21.8% in the CEI group (P<0.001) ( (Fig. 2) . Multiple logistic regression analysis showed that PIEBþPCEA compared with CEI was independently associated with a 31-fold reduction in the odds of motor block (OR 0.03, 95% CI: 0.01e0.14, P<0.001) after adjusting for maternal age, parity, and gestational age (Table S1) (Fig. 3) . Multiple linear regression analysis showed that PIEBþPCEA was independently associated with a reduction in the duration of the second stage of labour by 22 min compared with CEI (b¼À22.0, 95% CI: À35.7 to À8.3, P¼0.002) after adjusting for age, gestational age, and parity (Table S2) . There was no significant difference between PIEBþPCEA and CEI in maternal satisfaction or mode of delivery (Table 3) .
Discussion

Comparison with literature
We found a markedly reduced incidence of motor block from 21.8% to 1.0% (P<0.001) ( Table 3 and Fig. 2) , representing a 31-fold reduction in the adjusted odds of motor block (OR 0.03, 95% CI: 0.01e0.14, P<0.001). A meta-analysis of nine RCTs comparing PIEB and CEI 2 also demonstrated a reduction in motor block from 16% (CEI 28/175) to 2.8% (PIEB 5/180). The significant reduction in the incidence of motor block observed in our study is consistent with the concurrent marked reduction in total and hourly dose of local anaesthetic. It is worth noting that reducing the dose of ropivacaine from 0.2% to 0.1%, without changing method of delivery, has not been shown to reduce second stage of labour or reduce motor block or affect other obstetric outcomes. 6 A significant reduction in the duration of the second stage of labour by 25.4 min from 108.2 to 79.4 min (P<0.002) was observed in primiparous women in our study (Table 3 and Fig. 3 ), but not in multiparous women. Maternal age, parity, and gestational age were found to be significant covariates. After adjusting for these covariates, PIEBþPCEA was estimated to independently reduce the duration of the second stage of labour by 22 min compared with CEI (b¼À22.0, 95% CI: À35.7 to À8.3, P¼0.002). The meta-analysis of nine RCTs comparing PIEB and CEI demonstrated a reduction in the second stage of labour by 11.66 min (95% CI: 0.49e22.84, P¼0.04).
2
We found no statistically significant reductions in the rates of instrumental delivery or LSCS (Table 3) . This is consistent with the meta-analysis of nine RCTs comparing PIEB and CEI finding no difference in the rates of LSCS (OR 0.87, 95% CI: 0.56e1.35) or instrumental delivery (OR 0.59, 95% CI: 0.35e1.00). 2 However, point estimates of the rates observed in our study and previous RCTs demonstrate a consistent trend toward reduced incidence of instrumental delivery and LSCS. 7 Large RCTs powered to detect a change in this outcome are warranted.
The total dose of ropivacaine received by women in the PIEBþPCEA group was just more than half that in the CEI group [PIEBþPCEA 40.4 (23.8) mg vs CEI 72.5 (43.0) mg, P<0.001). This is equivalent to a 6 mg h À1 reduction in total ropivacaine dose [CEI 13.8 (6.21) mg h À1 vs PIEB 7.8 (3.21) mg h
À1
, P<0.001) ( Table 2 ). This is larger than the total dose reduction of only 1.2 (1) mg h À1 of bupivacaine in a meta-analysis of nine RCTs comparing PIEB and CEI. 2 This could be because of the reduction in local anaesthetic concentration between the two groups in this study whilst the studies in the meta-analysis of nine RCTs comparing PIEB and CEI 2 used the same solution in both groups.
Maternal satisfaction during the first and second stages of labour before and after instituting the change from the standard CEI protocol to PIEBþPCEA was not significantly different ( Table 3 ). The second stage satisfaction was reduced by 0.4 points on a 10-point verbal rating scale [PIEBþPCEA 9.0 (2.1) vs CEI 9.4 (1.8), P¼0.051]. We did not consider this to be significant as we had assumed a conservative significance level of P<0.01 to adjust for multiple comparisons (see statistical analysis above). In contrast, the meta-analysis of nine RCTs comparing PIEB and CEI 2 found increased maternal satisfaction by 7.01 points (PIEBþPCEA 95.6, CEI 89.0, P<0.001) on a 0e100 point visual analogue or verbal rating scale. This meant in our study PIEBþPCEA was as effective at meeting the subjective expectations of mothers as CEI, but not more so as in the previous meta-analysis of nine RCTs comparing PIEB and CEI. 2 The more marked decrease in the hourly dose of local anaesthetic (6 mg h À1 this study vs 1.2 mg h À1 meta-analysis of nine RCTs PIEB and CEI 2 ) mentioned in the paragraph above may have contributed to analgesia and therefore satisfaction being similar rather than increasing in the PIEBþPCEA group in our study. We did not measure pain outcomes directly, however, and satisfaction remained above 90% in both groups for the 1st and 2nd stage in this study.
Practical issues in the implementation of PIEB
Only recently has it been possible to administer PIEBþPCEA in a clinical setting. The first device approved by the Australian Therapeutic Goods Administration to administer PIEB (CADD ® -Solis epidural pump) only became commercially available in Australia in 2014.
Once a pump was available, the next challenge was developing the PIEBþPCEA protocol and deciding on specific analgesic solution, dose, and bolus intervals. There is no consensus among the previous RCTs. PIEB programmed vary from a bolus of 2.5 ml every 15 min 8 to 10 ml hourly. 9 Local anaesthetic solutions include bupivacaine, levobupivacaine, and ropivacaine. 2 We decided to use ropivacaine 0.1%, 5 ml hourly bolus and fentanyl 2 ug ml
À1
, so we could titrate up if required. A PCEA dose equal to the PIEB dose was programmed with a 10-min lockout period. The hourly maximum dose was 15 ml which would be equivalent to the maximum infusion rate of the standard CEI protocol. The bolus was administered at a rate or 250 ml h
.
Limitations
This study was a prospective, controlled, before-and-after cohort study without randomisation or blinding. Data from the two groups were collected sequentially so the results may be influenced by other concurrent changes in clinical practice during the trial period, although there were no other anaesthetic or obstetric protocol changes during the study period. The women who participated in this study and the medical and nursing staff involved were not blinded, and as such, may be affected by performance bias. However, it is difficult to blind study participants and personnel in RCTs comparing CEI with PIEBþPCEA because of distinctive patient-controlled analgesic systems. Recording maternal satisfaction during labour by the acute pain clinical nurse consultant or anaesthetic registrar on the following day may be subject to recall bias. We used multivariate analyses to adjust for potential confounding variables.
Well-designed RCTs minimise the risk of bias and achieve high internal validity, and are the gold standard for evaluating the efficacy of interventions. 10, 11 However, RCTs carefully conducted in controlled research conditions may not necessarily have high external validity or applicability (i.e. the findings may not necessarily translate into the 'real world' that contains much more diverse settings, patients, and practitioners). 12, 13 There is growing recognition of the importance of supplementing RCT evidence with observational evidence about the effectiveness of interventions in the 'real world' to inform best clinical practice. 14e16 This is particularly relevant for interventions that tend to more complex in nature and operator-dependent, such as an epidural infusion for labour analgesia. The nine RCTs summarised in a recent metaanalysis had small sample sizes of 20e75 women per arm and significant clinical and methodological heterogeneity among them. 2 Results of our study and other recent studies 3 that are based on a larger population and conducted in the complexities of the 'real world' externally validate the evidence from small RCTs. In addition to changing the protocol for epidural analgesia from CEI to PIEBþPCEA, we also changed the concentration of ropivacaine from 0.2% to 0.1%. In a comparative evaluation of two interventions, it is ideal to only change the intervention and hold as many other variables constant as possible. However, the objective of our study was to implement and evaluate a change in clinical practice in line with the best available evidence. The PIEB programme we adopted was used in two RCTs, 17, 18 and we felt afforded a higher margin of safety and flexibility as it was a lower dose. The optimal local anaesthetic agent, concentration, and dosing programme certainly warrants further investigation.
Conclusions
This study confirmed that the key benefits of PIEB over CEI demonstrated in small RCTs, including reductions in the incidence of motor block and the duration of the second stage of labour, can be reproduced on a larger scale in a 'real world' clinical setting. We have provided a model for the translation and implementation of this evidence-based practice in an Australian tertiary hospital. We recommend PIEBþPCEA as a feasible, evidence-based and patient-centred practice to other institutions that use the standard CEI protocol for labour analgesia. Further investigations into the optimal local anaesthetic agent, concentration, and dosing programme for PIEB, and the role of additional PCEA are needed.
